Literature DB >> 17931692

An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuata.

Brian Quinn1, François Gagné, Christian Blaise.   

Abstract

Pharmaceuticals previously identified in the effluent from the wastewater treatment plant (WWTP) in Montreal discharging into the St. Lawrence river, were tested for acute and chronic toxicity using the cnidarian Hydra attenuata. Acute toxicity was based on the established technique looking at morphological changes in the Hydra, while recently developed endpoints of feeding behaviour, attachment and growth (hydranth number) were used to measure chronic effects. The compounds under investigation (ibuprofen, naproxen, gemfibrozil, bezafibrate, carbamazepine, sulfamethoxazole, sulfapyridine, oxytetracycline, novobiocin, trimethoprim and caffeine) were tested individually in controlled laboratory exposures with LC(50) and EC(50) results calculated. All compounds tested had relatively high LC(50) values with gemfibrozil, ibuprofen and naproxen having the lowest at 22.36 mg/L and EC(50) values based on morphology of 1.18 to 2.62 mg/L (all concentrations are nominal). The EC(50) values based on feeding were similar to those based on morphology but with increased sensitivity for carbamazepine, bezafibrate and novobiocin. A trend of a reduction in feeding with deterioration in morphology was observed in the Hydra, with the exception of novobiocin, where a lower than expected EC(50) of 13.53 mg/L was found with no negative effect on morphology. Significant reductions in attachment and hydranth number were seen at concentrations of 1 and 5 mg/L for gemfibrozil and ibuprofen respectively. A toxicity threshold (TT) of 320 microg/L was calculated for ibuprofen, only a factor of 10(2) or 10 higher than the concentration found in the effluent in the present study (1.19 mug/L) and in other Canadian effluents studied (22 microg/L [Brun GL, Bernier M, Losier R, Doe K, Jackman P, Lee HB, Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ Toxicol Chem 2006; 25(8): 2163-2176.] respectively. Using EU directive 93/67/EEC the pharmaceuticals under investigation can be classified as toxic (gemfibrozil, ibuprofen and naproxen), harmful (carbamazepine, bezafibrate, sulfapyridine, oxytetracycline and novobiocin) and non-toxic (sulfamethoxazole, trimethoprim and caffeine) and their potential toxicity for the aquatic environment is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17931692     DOI: 10.1016/j.scitotenv.2007.08.038

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  38 in total

1.  Occurrence of pharmaceuticals, hormones, and perfluorinated compounds in groundwater in Taiwan.

Authors:  Yen-Ching Lin; Webber Wei-Po Lai; Hsin-hsin Tung; Angela Yu-Chen Lin
Journal:  Environ Monit Assess       Date:  2015-04-16       Impact factor: 2.513

2.  Toxic effect and adaptation in Scenedesmus intermedius to anthropogenic chloramphenicol contamination: genetic versus physiological mechanisms to rapid acquisition of xenobiotic resistance.

Authors:  S Sánchez-Fortún; F Marvá; M Rouco; E Costas; V López-Rodas
Journal:  Ecotoxicology       Date:  2009-03-25       Impact factor: 2.823

3.  The Hydra regeneration assay reveals ecological risks in running waters: a new proposal to detect environmental teratogenic threats.

Authors:  Lorenzo Traversetti; Floriano Del Grosso; Valentina Malafoglia; Marco Colasanti; Simona Ceschin; Stefano Larsen; Massimiliano Scalici
Journal:  Ecotoxicology       Date:  2016-12-19       Impact factor: 2.823

4.  Occurrence of pharmaceuticals in WWTP effluents and their impact in a karstic rural catchment of Eastern France.

Authors:  Axelle Chiffre; François Degiorgi; Audrey Buleté; Loïc Spinner; Pierre-Marie Badot
Journal:  Environ Sci Pollut Res Int       Date:  2016-10-03       Impact factor: 4.223

5.  Assessment of plant-driven uptake and translocation of clofibric acid by Scirpus validus.

Authors:  Dong Qing Zhang; Richard M Gersberg; Tao Hua; Junfei Zhu; Wun Jern Ng; Soon Keat Tan
Journal:  Environ Sci Pollut Res Int       Date:  2012-12-30       Impact factor: 4.223

6.  Stability of lysosomal membrane in Carcinus maenas acts as a biomarker of exposure to pharmaceuticals.

Authors:  G V Aguirre-Martínez; S Buratti; E Fabbri; T A Del Valls; M L Martín-Díaz
Journal:  Environ Monit Assess       Date:  2012-11-07       Impact factor: 2.513

7.  Pharmaceutical occurrence in groundwater and surface waters in forests land-applied with municipal wastewater.

Authors:  Andrew D McEachran; Damian Shea; Wanda Bodnar; Elizabeth Guthrie Nichols
Journal:  Environ Toxicol Chem       Date:  2015-12-09       Impact factor: 3.742

8.  Environmental effects of anticholinesterasic therapeutic drugs on a crustacean species, Daphnia magna.

Authors:  R Rocha; F Gonçalves; C Marques; B Nunes
Journal:  Environ Sci Pollut Res Int       Date:  2013-12-11       Impact factor: 4.223

9.  Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents.

Authors:  Patrick J Phillips; Steven G Smith; D W Kolpin; Steven D Zaugg; Herbert T Buxton; Edward T Furlong; Kathleen Esposito; Beverley Stinson
Journal:  Environ Sci Technol       Date:  2010-07-01       Impact factor: 9.028

10.  Removal of selected pharmaceuticals from aqueous solution using magnetic chitosan: sorption behavior and mechanism.

Authors:  Yalei Zhang; Zhe Shen; Chaomeng Dai; Xuefei Zhou
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-28       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.